T47.1X3
Poisoning by other antacids and anti-gastric-secretion drugs, assault
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T47.1X3 describes a specific case of poisoning caused by the ingestion or exposure to antacids and anti-gastric-secretion medications due to assault. Such incidents involve intentional harm and are considered a form of poisoning that requires medical attention. Recognizing this condition is essential for healthcare providers to deliver appropriate treatment and support to affected individuals. This guide provides an overview of this code, including causes, symptoms, diagnosis, and general treatment considerations, in a clear and patient-friendly manner.
Causes & Symptoms
Clinical Causes: Intentional overdose or ingestion of antacid medications during assault Use of anti-gastric-secretion drugs with harmful intent Situations where these medications are misused or taken maliciously Lack of proper storage leading to unauthorized access
Key Symptoms: Nausea and vomiting Abdominal pain or discomfort Dizziness or lightheadedness Confusion or altered mental state Slow or irregular heartbeat Weakness or fatigue Respiratory difficulties in severe cases Possible aggravation of pre-existing conditions such as kidney issues
Diagnostic & Treatment
Diagnosis Path: Healthcare providers diagnose this poisoning based on a combination of patient history, clinical signs, and laboratory tests. The diagnosis process may include:
Treatment Protocols: Management of poisoning by antacids and anti-gastric-secretion drugs in assault cases involves various steps aimed at stabilizing the patient, reducing medication levels, and treating symptoms:
Clinical Advice & FAQs
Billing Guidance
Is T47.1X3 a billable ICD-10 code?
Yes, T47.1X3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T47.1X3?
Clinical documentation must specify the nature of Poisoning by other antacids and anti-gastric-secretion drugs, assault and any associated comorbidities for accurate reporting.
Cite this Clinical Reference